192 related articles for article (PubMed ID: 28590477)
1. Evaluation of ligand-based NMR screening methods to characterize small molecule binding to HIV-1 glycoprotein-41.
Chu S; Zhou G; Gochin M
Org Biomol Chem; 2017 Jun; 15(24):5210-5219. PubMed ID: 28590477
[TBL] [Abstract][Full Text] [Related]
2. Conformational flexibility of the conserved hydrophobic pocket of HIV-1 gp41. Implications for the discovery of small-molecule fusion inhibitors.
Cano-Muñoz M; Jurado S; Morel B; Conejero-Lara F
Int J Biol Macromol; 2021 Dec; 192():90-99. PubMed ID: 34619276
[TBL] [Abstract][Full Text] [Related]
3. Identification of fragments targeting an alternative pocket on HIV-1 gp41 by NMR screening and similarity searching.
Chu S; Gochin M
Bioorg Med Chem Lett; 2013 Sep; 23(18):5114-8. PubMed ID: 23932360
[TBL] [Abstract][Full Text] [Related]
4. NMR second site screening for structure determination of ligands bound in the hydrophobic pocket of HIV-1 gp41.
Balogh E; Wu D; Zhou G; Gochin M
J Am Chem Soc; 2009 Mar; 131(8):2821-3. PubMed ID: 19206471
[TBL] [Abstract][Full Text] [Related]
5. Anti-HIV-1 Activity Prediction of Novel Gp41 Inhibitors Using Structure-Based Virtual Screening and Molecular Dynamics Simulation.
Sepehri S; Saghaie L; Fassihi A
Mol Inform; 2017 Mar; 36(3):. PubMed ID: 27730744
[TBL] [Abstract][Full Text] [Related]
6. A targeted covalent small molecule inhibitor of HIV-1 fusion.
Zhou G; He L; Li KH; Pedroso CCS; Gochin M
Chem Commun (Camb); 2021 May; 57(37):4528-4531. PubMed ID: 33956029
[TBL] [Abstract][Full Text] [Related]
7. Development of HIV-1 fusion inhibitors targeting gp41.
Lu K; Asyifah MR; Shao F; Zhang D
Curr Med Chem; 2014 Jun; 21(17):1976-96. PubMed ID: 24350848
[TBL] [Abstract][Full Text] [Related]
8. Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket.
Gochin M; Zhou G; Phillips AH
ACS Chem Biol; 2011 Mar; 6(3):267-74. PubMed ID: 21155611
[TBL] [Abstract][Full Text] [Related]
9. Interaction of lafutidine in binding to human serum albumin in gastric ulcer therapy: STD-NMR, WaterLOGSY-NMR, NMR relaxation times, Tr-NOESY, molecule docking, and spectroscopic studies.
Yang H; Huang Y; He J; Li S; Tang B; Li H
Arch Biochem Biophys; 2016 Sep; 606():81-9. PubMed ID: 27457418
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitors.
Zhou G; Chu S; Nemati A; Huang C; Snyder BA; Ptak RG; Gochin M
Eur J Med Chem; 2019 Jan; 161():533-542. PubMed ID: 30390441
[TBL] [Abstract][Full Text] [Related]
11. Biophysical studies of HIV-1 glycoprotein-41 interactions with peptides and small molecules - Effect of lipids and detergents.
Zhou G; Chu S; Kohli A; Szoka FC; Gochin M
Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129724. PubMed ID: 32889078
[TBL] [Abstract][Full Text] [Related]
12. Design and characterization of swapped-domain constructs of HIV-1 glycoprotein-41 as receptors for drug discovery.
Walsh JD; Chu S; Zhang SQ; Gochin M
Protein Eng Des Sel; 2015 Apr; 28(4):107-16. PubMed ID: 25792539
[TBL] [Abstract][Full Text] [Related]
13. Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.
Lu L; Yu F; Cai L; Debnath AK; Jiang S
Curr Top Med Chem; 2016; 16(10):1074-90. PubMed ID: 26324044
[TBL] [Abstract][Full Text] [Related]
14. Gp41 inhibitory activity prediction of theaflavin derivatives using ligand/structure-based virtual screening approaches.
Mostashari-Rad T; Saghaei L; Fassihi A
Comput Biol Chem; 2019 Apr; 79():119-126. PubMed ID: 30785021
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation.
Allen WJ; Yi HA; Gochin M; Jacobs A; Rizzo RC
Bioorg Med Chem Lett; 2015 Jul; 25(14):2853-9. PubMed ID: 26013847
[TBL] [Abstract][Full Text] [Related]
16. Applications of NMR screening techniques to the pharmaceutical target Checkpoint kinase 1.
Lancelot N; Piotto M; Theret I; Lesur B; Hennig P
J Pharm Biomed Anal; 2014 May; 93():125-35. PubMed ID: 24280017
[TBL] [Abstract][Full Text] [Related]
17. A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin.
Wensel D; Sun Y; Davis J; Li Z; Zhang S; McDonagh T; Fabrizio D; Cockett M; Krystal M
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743355
[TBL] [Abstract][Full Text] [Related]
18. pH-dependent vesicle fusion induced by the ectodomain of the human immunodeficiency virus membrane fusion protein gp41: Two kinetically distinct processes and fully-membrane-associated gp41 with predominant β sheet fusion peptide conformation.
Ratnayake PU; Sackett K; Nethercott MJ; Weliky DP
Biochim Biophys Acta; 2015 Jan; 1848(1 Pt B):289-98. PubMed ID: 25078440
[TBL] [Abstract][Full Text] [Related]
19. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors.
Zhu Y; Ding X; Yu D; Chong H; He Y
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619552
[TBL] [Abstract][Full Text] [Related]
20. Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 glycoprotein-41.
Zhou G; Wu D; Snyder B; Ptak RG; Kaur H; Gochin M
J Med Chem; 2011 Oct; 54(20):7220-31. PubMed ID: 21928824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
